paclitaxel

Paclitaxel (Taxol) 属于天然产物，是一种微管聚合物稳定剂。Paclitaxel 具有抗肿瘤活性；通过诱导有丝分裂停滞、细胞凋亡、细胞自噬等，导致细胞死亡。

7-O-(Amino-PEG4)-paclitaxel is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells.

7-O-(Cbz-N-amido-PEG4)-paclitaxel is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells.

7-acetyl Paclitaxel，作为一种微管脱聚抑制剂，在10 µM浓度下可阻止由钙离子引起的微管脱聚。此化合物还能有效抑制J774.2巨噬细胞增生（IC50约60 nM），并在分离的小鼠腹腔巨噬细胞中增加一氧化氮（NO）与肿瘤坏死因子（TNF）水平。

Paclitaxel Poliglumex is cyclohexane isolated from the bark of the Pacific yew tree.

Paclitaxel-SMCC is a paclitaxel derivative with a SMCC linker. (Succinimidyl-4-( N -maleimidomethyl)cyclohexane-1-carboxylate). Paclitaxel-SMCC can be used to synthesize Paclitaxel bioconjugates with enzymes, antobodies, antigens and other biopolymers. Pa

Paclitaxel-MVCP ( MC-val-cit-pab-paclitaxel )is a paclitaxel derivative with an MC-Val-Cit-PAB linker, which can be used for the preparation of Paclitaxel conjugates for drug delivery and nanomedicine research.

Paclitaxel-Succinic acid (paclitaxel-succinate , paclitaxel-semisucinic acid)is a paclitaxel derivative with a succinic acid linker. Paclitaxel-Succinic acid can be used to prepare paclitaxel conjugates for drug delivery and nanomedicine research.

Paclitaxel octadecanedioate is a prodrug form of paclitaxel that is comprised of paclitaxel conjugated to 1,18-octadecanedioic acid.1 Unlike paclitaxel, it does not promote tubulin polymerization in vitro when used at a concentration of 10 μM. A 5:1 mixture of paclitaxel octadecanedioate:human serum albumin (HSA) is cytotoxic to HT-1080, PANC-1, and HT-29 cells (IC50s = 12, 2.48, and 8.62 nM, respectively). This mixture reduces tumor growth and increases survival in an HT-1080 mouse xenograft model in a dose-dependent manner. |1. Callmann, C.E., Leguyader, C.L.M., Burton, S.T., et al. Antitumor activity of 1,18-octadecanedioic acid-paclitaxel complexed with human serum albumin. J. Am. Chem. Soc. 141(30), 11765-11769 (2019).

DHA-paclitaxel, also know as Taxoprexin, is prodrug comprised of the naturally occurring omega-3 fatty acid docosahexaenoic acid (DHA) covalently conjugated to the anti-microtubule agent paclitaxel. Because tumor cells take up DHA, DHA-paclitaxel is delivered directly to tumor tissue, where the paclitaxel moiety binds to tubulin and inhibits the disassembly of microtubules, thereby resulting in the inhibition of cell division. Paclitaxel also induces apoptosis by binding to and blocking the function of the apoptosis inhibitor protein Bcl-2 (B-cell Leukemia 2). DHA-paclitaxel exhibits improved pharmacokinetic and toxicity profiles when compared to conventional paclitaxel and has demonstrated antineoplastic activity in animal models of cancer.

Paclitaxel Ceribate is a mitotic inhibitor used in cancer chemotherapy.

Paclitaxel-d5 是 Paclitaxel 的氘代化合物。Paclitaxel 的 CAS 号为 33069-62-4。Paclitaxel 是一种从太平洋紫杉树皮中分离出来的环癸烷。 它以聚合形式稳定微管，导致细胞死亡。

7-Troc-paclitaxel 是紫杉醇的前体，紫杉醇具有抗肿瘤活性。

6α-hydroxy Paclitaxel (6α-OH-PTX) 是抗癌化合物紫杉醇的主要代谢产物，具有部分细胞毒性。

7-Epi 10-desacetyl paclitaxel (10-Deacetyl-7-epipaclitaxel) 是紫杉醇衍生物，对 HeLa 细胞具有细胞毒性(IC50:85 μM)。

10-Deacetyl-7-xylosyl paclitaxel (7-Xylosyl-10-deacetyltaxol) 是一种紫杉醇衍生物，具有改进的药理特性和更高的水溶性，用于治疗癌症。

Nab-Paclitaxel为一种Paclitaxel纳米颗粒与白蛋白结合的制剂，展现出较高的疗效及耐受性。通过利用白蛋白传递Paclitaxel，Abraxane形成优异的药代动力学特性。

7-epi-Taxol (7-Epitaxol) 是在细胞中发现的紫杉醇的主要衍生物，在抑制细胞增殖、微管解离和诱导微管聚合等方面与紫杉醇作用相当。

10-Deacetyltaxol (10-DAT) 是从红豆杉中分离得到的一种紫杉醇衍生物，对人脑胶质细胞瘤和神经母细胞瘤细胞具有细胞毒性。它能促进微管蛋白的聚合，在体外抑制由钙离子诱导的微管解聚。

LY3325656 is a GPR142 agonist suitable for clinical testing in human. LY3325656 demonstrated anti-diabetic benefits in pre-clinical studies and ADME PK properties suitable for human dosing. LY3325656 is the first GPR142 agonist molecule advancing to phase 1 clinic trials for the treatment of Type 2 diabetes.

NSC756093 可能抑制 GBP1:PIM1 相互作用。 NSC756093 可用于卵巢癌研究。

DB04760 是一种高选择性和有效的 MMP-13 非锌螯合抑制剂（IC50：8 nM）。DB04760 能明显降低紫杉醇的神经毒性，并具有抗癌活性。

(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl dihydrogen diphosphate,tetrabutylammonium(1:1.5) 是紫杉二烯，如紫杉醇，的常见前体。

Geranylgeranyl pyrophosphate tetrabutylammonium(1：2)是甲羟戊酸途径产生内源性胆固醇和中间体之一。Geranylgeranyl pyrophosphate tetrabutylammonium(1：2) 香叶基香叶基焦磷酸三铵是二萜类化合物的常见前体，例如紫杉醇，可用于癌症研究。